1 month Amgen Dives 5% Despite ‘Truly Remarkable’ Results For Obesity Treatment Investor's Business Daily
Amgen stock tumbled Tuesday after its weight-loss drug met Wall Street’s expectations, but was only on par with Eli Lilly’s Zepbound.
The post Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment appeared first on Investor&…
Amgen (AMGN) · Eli Lilly (LLY) · Wall Street
X